Literature DB >> 15647219

When is evidence sufficient?

Karl Claxton1, Joshua T Cohen, Peter J Neumann.   

Abstract

Traditional conceptualizations of evidence-based medicine rely heavily on randomized controlled trials. Although initiatives to broaden definitions of evidence have been advanced, they generally have not tied evidentiary criteria formally and quantitatively to the benefits and costs involved in a decision to adopt or reject an intervention. Decision analysis provides a framework for combining information to inform the adoption decision in this manner. Value-of-information analysis, a related methodology, helps to determine whether it is worthwhile to collect additional information as well as the type of research that would be most helpful.

Mesh:

Year:  2005        PMID: 15647219     DOI: 10.1377/hlthaff.24.1.93

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  14 in total

1.  AcademyHealth 25th Annual Research Meeting chair address: From a science of recommendation to a science of implementation.

Authors:  Margarita Alegria
Journal:  Health Serv Res       Date:  2009-02       Impact factor: 3.402

2.  Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling.

Authors:  Hawre Jalal; Jeremy D Goldhaber-Fiebert; Karen M Kuntz
Journal:  Med Decis Making       Date:  2015-04-03       Impact factor: 2.583

Review 3.  A systematic and critical review of the evolving methods and applications of value of information in academia and practice.

Authors:  Lotte Steuten; Gijs van de Wetering; Karin Groothuis-Oudshoorn; Valesca Retèl
Journal:  Pharmacoeconomics       Date:  2013-01       Impact factor: 4.981

4.  Some Health States Are Better Than Others: Using Health State Rank Order to Improve Probabilistic Analyses.

Authors:  Jeremy D Goldhaber-Fiebert; Hawre J Jalal
Journal:  Med Decis Making       Date:  2015-09-16       Impact factor: 2.583

5.  The economics of comparative effectiveness studies: societal and private perspectives and their implications for prioritizing public investments in comparative effectiveness research.

Authors:  David Meltzer; Anirban Basu; Rena Conti
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

6.  A method for addressing research gaps in HTA, developed whilst evaluating robotic-assisted surgery: a proposal.

Authors:  Luciana Ballini; Silvia Minozzi; Antonella Negro; Giampiero Pirini; Roberto Grilli
Journal:  Health Res Policy Syst       Date:  2010-09-20

7.  Private manufacturers' thresholds to invest in comparative effectiveness trials.

Authors:  Anirban Basu; David Meltzer
Journal:  Pharmacoeconomics       Date:  2012-10-01       Impact factor: 4.981

8.  Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis.

Authors:  Katrina Abuabara; Joy Wan; Andrea B Troxel; Daniel B Shin; Abby S Van Voorhees; Bruce F Bebo; Gerald G Krueger; Kristina Callis Duffin; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2012-08-19       Impact factor: 11.527

9.  Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis: cost-utility analysis using a Markov model.

Authors:  Simon Kreck; Jochen Klaus; Reiner Leidl; Christian von Tirpitz; Alexander Konnopka; Herbert Matschinger; Hans-Helmut König
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

10.  Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations.

Authors:  Steven Woolf; Holger J Schünemann; Martin P Eccles; Jeremy M Grimshaw; Paul Shekelle
Journal:  Implement Sci       Date:  2012-07-04       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.